#gsk — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #gsk, aggregated by home.social.
-
GSK to Advance mRNA Influenza Vaccine Into Phase III Development
GSK plc GSK announced that it plans to advance the mRNA-based seasonal influenza (flu) vaccine candidate into late-stage development.…
#EuropeSays #Britain #Europe #EU #GSK #AnikaTherapeutics #AnikaTherapeuticsANIK #GSKPLCSponsoredADR #PLC) #Repligen #RepligenRGEN #Zacks #ZacksInvestmentResearch
https://www.europesays.com/britain/118817/ -
https://www.europesays.com/britain/118817/ GSK to Advance mRNA Influenza Vaccine Into Phase III Development #AnikaTherapeutics #AnikaTherapeuticsANIK #GSK #GSKPLCSponsoredADR #PLC) #Repligen #RepligenRGEN #Zacks #ZacksInvestmentResearch
-
GSK (LSE:GSK), What Is Behind The Latest Attention?
GSK (LSE:GSK) is back in focus after presenting positive phase II data for its mRNA seasonal flu vaccine…
#EuropeSays #Britain #Europe #EU #GSK
https://www.europesays.com/britain/118415/ -
https://www.europesays.com/britain/118415/ GSK (LSE:GSK), What Is Behind The Latest Attention? #GSK
-
https://www.europesays.com/britain/?p=118119 Mobile livescore – Flashscore.mobi football scores #GSK
-
GSK advances mRNA flu vaccine to phase 3 after positive results
(Alliance News) – GSK PLC on Tuesday said a phase 2 probe of its mRNA flu vaccine candidate…
#EuropeSays #Britain #Europe #EU #GSK
https://www.europesays.com/britain/117985/ -
https://www.europesays.com/britain/117985/ GSK advances mRNA flu vaccine to phase 3 after positive results #GSK
-
Hutchmed China inks USD1.30 billion GSK deal for cancer drug HMPL-A830
(Alliance News) – Hutchmed China PLC on Thursday announced that its subsidiary, Hutchmed Ltd, has entered into an…
#EuropeSays #Britain #Europe #EU #GSK
https://www.europesays.com/britain/117974/ -
https://www.europesays.com/britain/117974/ Hutchmed China inks USD1.30 billion GSK deal for cancer drug HMPL-A830 #GSK
-
Can GSK’s Hepatitis B Breakthrough Become a £2 Billion Opportunity?
GSK plc (NYSE:GSK) has reached two important regulatory milestones involving treatments for chronic hepatitis B and rectal cancer.…
#EuropeSays #Britain #Europe #EU #GSK #GSKplc #Jemperli #NYSE
https://www.europesays.com/britain/117964/ -
https://www.europesays.com/britain/117964/ Can GSK’s Hepatitis B Breakthrough Become a £2 Billion Opportunity? #GSK #GSKPlc #Jemperli #NYSE
-
Hesham A. Abdullah Announces a New Oncology Partnership Between GSK and HUTCHMED
Hesham A. Abdullah/LinkedIn Hesham A. Abdullah, Senior Vice President of Global Head Oncology, Research and Development at GSK…
#EuropeSays #Britain #Europe #EU #GSK
https://www.europesays.com/britain/117866/ -
https://www.europesays.com/britain/117866/ Hesham A. Abdullah Announces a New Oncology Partnership Between GSK and HUTCHMED #GSK
-
HUTCHMED Secures $110 Million Licensing Deal with GSK for Promising Solid Tumour Drug, ETPharma
Shanghai: GSK subsidiary GlaxoSmithKline Intellectual Property (No. 4) Ltd will pay a unit of HUTCHMED (China) $110 million…
#EuropeSays #Britain #Europe #EU #GSK #experimentalsolidtumourdrug #GlaxoSmithKline #HMPL-A830 #HUTCHMEDlicensingdeal #solidtumours
https://www.europesays.com/britain/117654/ -
https://www.europesays.com/britain/117654/ HUTCHMED Secures $110 Million Licensing Deal with GSK for Promising Solid Tumour Drug, ETPharma #ExperimentalSolidTumourDrug #GlaxoSmithKline #GSK #HMPLA830 #HUTCHMEDLicensingDeal #SolidTumours
-
GSK advances mRNA flu shot after Phase II success
Drugmaker GSK said on Tuesday that it will move its mRNA seasonal flu vaccine candidate into Phase III…
#EuropeSays #Britain #Europe #EU #GSK #advances #after #Category:All #Category:CompanyNews #Category:MarketPulse #Category:MarketReport #Category:NewsandAnnouncements #Category:Sectorial:HealthTechnology #mRNA #Phase #shot #success
https://www.europesays.com/britain/117636/ -
Hutchmed, GSK Ink $1.3B Cancer Drug Deal
Hutchmed Limited has entered into an exclusive development and license agreement with a subsidiary of GSK plc, giving…
#EuropeSays #Britain #Europe #EU #GSK
https://www.europesays.com/britain/117616/ -
https://www.europesays.com/britain/117616/ Hutchmed, GSK Ink $1.3B Cancer Drug Deal #GSK
-
Is GSK (LSE:GSK) Still Reasonable, Or Is The Value Already Priced In?
GSK stock has delivered a strong 54.4% gain over the past 5 years, yet the current checks still…
#EuropeSays #Britain #Europe #EU #GSK
https://www.europesays.com/britain/117597/ -
https://www.europesays.com/britain/117597/ Is GSK (LSE:GSK) Still Reasonable, Or Is The Value Already Priced In? #GSK
-
GSK (LSE:GSK) Wins First Global Approval For Chronic Hepatitis B Functional Cure
GSK (LSE:GSK) has received the world’s first regulatory approval for Hibsago (bepirovirsen) as a functional cure for chronic…
#EuropeSays #Britain #Europe #EU #GSK
https://www.europesays.com/britain/117584/ -
https://www.europesays.com/britain/117584/ GSK (LSE:GSK) Wins First Global Approval For Chronic Hepatitis B Functional Cure #GSK
-
China’s Hutchmed inks $1.3 B deal with GSK for KRAS-EGFR-antibody conjugate cancer therapy
China’s Hutchmed inks $1.3 B deal with GSK for KRAS-EGFR-antibody conjugate cancer therapy September 4, 2026 | Friday…
#EuropeSays #Britain #Europe #EU #GSK #Cancer #China #EGFR #Hutchmed #KRAS
https://www.europesays.com/britain/117573/ -
HUTCHMED (China) signs licensing deal with GSK for experimental solid tumour drug
Sept 3 (Reuters) – GSK subsidiary GlaxoSmithKline Intellectual Property (No. 4) Ltd will pay a unit of HUTCHMED…
#EuropeSays #Britain #Europe #EU #GSK #Markets
https://www.europesays.com/britain/117557/ -
https://www.europesays.com/britain/117557/ HUTCHMED (China) signs licensing deal with GSK for experimental solid tumour drug #GSK #Markets
-
GSK to Advance mRNA Influenza Vaccine Into Phase III Development
GSK plc GSK announced that it plans to advance the mRNA-based seasonal influenza (flu) vaccine candidate into late-stage development.…
#EuropeSays #Britain #Europe #EU #GSK #AnikaTherapeutics #AnikaTherapeuticsANIK #GSKPLCSponsoredADR #PLC) #Repligen #RepligenRGEN #Zacks #ZacksInvestmentResearch
https://www.europesays.com/britain/117543/ -
https://www.europesays.com/britain/117543/ GSK to Advance mRNA Influenza Vaccine Into Phase III Development #AnikaTherapeutics #AnikaTherapeuticsANIK #GSK #GSKPLCSponsoredADR #PLC) #Repligen #RepligenRGEN #Zacks #ZacksInvestmentResearch
-
GSK’s mRNA flu vaccine data closely tracks Moderna’s, Deutsche Bank says
GSK’s mRNA flu vaccine data closely tracks Moderna’s, Deutsche Bank says Proactive uses images sourced from Shutterstock GSK…
#EuropeSays #Britain #Europe #EU #GSK #deutschebank #Moderna
https://www.europesays.com/britain/117528/ -
https://www.europesays.com/britain/117528/ GSK’s mRNA flu vaccine data closely tracks Moderna’s, Deutsche Bank says #DeutscheBank #GSK #Moderna
-
Is GSK (LSE:GSK) Losing The Room As Vaccine Demand Questions Resurface?
Highlights GSK featured among the sharpest decliners on London’s leading benchmark Vaccine demand patterns remain the most closely…
#EuropeSays #Britain #Europe #EU #GSK #IsGSK(LSE:GSK)LosingTheRoomAsVaccineDemandQuestionsResurface?
https://www.europesays.com/britain/117512/ -
GSK launches £2bn cost savings drive, confirms new Cambridge hub
GSK unveiled sweeping cost-saving plans on Tuesday as part of moves to ramp up research and development, including…
#EuropeSays #Britain #Europe #EU #GSK #£2bn #Cambridge #Category:All #Category:CompanyNews #Category:HeadlineNews #Category:NewsandAnnouncements #Category:Sectorial:HealthTechnology #confirms #cost #drive #launches #mostread_company_news #Savings
https://www.europesays.com/britain/92476/ -
https://www.europesays.com/britain/92476/ GSK launches £2bn cost savings drive, confirms new Cambridge hub #£2bn #Cambridge #Category:All #Category:CompanyNews #Category:HeadlineNews #Category:NewsAndAnnouncements #Category:Sectorial:HealthTechnology #confirms #cost #drive #GSK #launches #mostread_company_news #Savings
-
GSK to cut jobs amid £1.9bn cost-cutting plan and bid for faster drug development
By Joanna PartridgePharmaceuticals company is investing £400m in UK life sciences and moving scientists to new Cambridge R&D site
#Pharmaceuticalsindustry #GSK #Business #Biotechnologyindustry #UKnews #Science #Cambridge #Cambridgeshire #Hertfordshire #Stevenage #TheGuardian #JoannaPartridge
-
GSK to cut jobs amid £1.9bn cost-cutting plan and bid for faster drug development https://www.theguardian.com/business/2026/jul/28/gsk-cut-jobs-cost-cutting-faster-drug-development-cambridge #PharmaceuticalsIndustry #Gsk #Business #BiotechnologyIndustry #UkNews #Science #Cambridge #Cambridgeshire #Hertfordshire #Stevenage
-
https://www.europesays.com/britain/59198/ Stocks making the biggest moves premarket: GSK, Nuvalent, J.M. Smucker, SailPoint and more #AlibabaGroupHoldingLtd #BaiduInc #BoydGamingCorp #BreakingNews:Markets #Business #BusinessNews #Economy #GSK #GSKPlc #JMSmuckerCo #MarketInsider #Markets #MicronTechnologyInc #NuvalentInc #QualcommInc #RegwallPro #SailPointInc #StockMarkets #UnitedStates #VailResortsInc #VanEckSemiconductorETF
-
Although #RSV is a serious #health issue, this RSV #ad by #GSK promoting their medication is disruptive in the home and also causes auditory issues for me and others with certain health issues and it needs to get pulled off the air, esp local TV stations
Imagine this going off randomly in your home, esp in surround sound with #auditory triggers with your #autonomic disease. #Marketing #TV #Advertising #neuroscience
( Starts Halfway through)
-
Former Trump vaccine czar fired over substantiated sexual harassment claim - Enlarge / President Donald Trump listens as Moncef Slaoui, the former head of GlaxoSmithKlines vacc... - https://arstechnica.com/?p=1752031 #operationwarpspeed #sexualharassment #vaccines #science #slaoui #trump #gsk